Liposome Drug Delivery Market was valued at US$ 3.6 Bn in 2018 and is projected to expand at a considerable CAGR from 2019 to 2027, the market is driven by rise in prevalence of cancer, technological advances, and strong pipeline of drugs
Global Liposome Drug Delivery Market: Introduction
According to the report, the global liposome drug delivery market was valued at US$ 3.6 Bn in 2018 and
is projected to expand at a considerable CAGR during the forecast period. Liposomes are considered novel
drug delivery systems and defined as the vesicular structures consisting of bilayers formed spontaneously
when phospholipids are dispersed in water. Liposomes aid in delivering drugs by the process of diffusion
rather than direct cell fusion. The global liposome drug delivery market is driven by increase in therapeutic
and diagnostic applications. Therapeutic applications include anti-fungal, anti-cancer, and anti-
inflammatory drugs, in addition to therapeutic gene delivery. Major drugs formulated using liposome drug
delivery are Doxil, AmBisome, and DepoDur. Liposomes also play an integral part in individualized
medicine. Applications include accurate disease diagnosis, monitoring drug delivery, determining therapy
response, and guiding minimally invasive surgeries.
Request Brochure of Report -
North America dominated the global liposome drug delivery market in 2018 and the trend is anticipated
to continue during the forecast period. The U.S. FDA received over 400 liposomal drug product
submissions in the past few years; over eight products have been approved for sale in the U.S. Among the
product submissions received, over 96% were investigational new drug (IND) applications, around 3%
were new drug applications (NDAs), and over 1% were abbreviated new drug applications (ANDAs).
Advantages of Liposome Drug Delivery
Liposomes are considered highly common and well-investigated nanocarriers for targeted drug delivery.
Liposomes can be defined as phospholipid vesicles, which consist of one or more concentric lipid bilayers
enclosed in discrete aqueous spaces. Both conventional and stealth liposomes have a natural ability to
enhance the localization of anticanc